CORLINE BIOMEDICAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.1 SEK | +0.50% |
|
-3.35% | -32.21% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 36M 3.32M | Sales 2025 * | 60M 5.53M | Capitalization | 217M 20.02M |
|---|---|---|---|---|---|
| Net income 2024 * | -11M -1.01M | Net income 2025 * | 20M 1.84M | EV / Sales 2024 * | 5.58 x |
| Net cash position 2024 * | 16M 1.48M | Net cash position 2025 * | 30M 2.77M | EV / Sales 2025 * | 3.12 x |
| P/E ratio 2024 * |
-20.2
x | P/E ratio 2025 * |
11.1
x | Employees | 13 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.50% | ||
| 1 week | -3.35% | ||
| Current month | -4.27% | ||
| 1 month | -14.04% | ||
| 3 months | -27.34% | ||
| 6 months | -21.09% | ||
| Current year | -32.21% |
1 week
9.64
10.45
1 month
9.6411.75
Current year
9.6416.80
1 year
9.6419.30
3 years
7.6019.85
5 years
7.6026.60
10 years
6.4031.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 07-12-31 | |
Gunnar Tufveson
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Fredrik Carlsson
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Magnus Nilsson
BRD | Director/Board Member | 68 | 20-11-17 |
| Director/Board Member | - | 04-12-31 | |
| Chairman | 51 | 04-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 10.1 | +0.50% | 9,275 |
| 24-05-08 | 10.05 | 0.00% | 898 |
| 24-05-07 | 10.05 | -1.95% | 14,881 |
| 24-05-06 | 10.25 | -1.91% | 4,847 |
| 24-05-03 | 10.45 | -0.95% | 10,239 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 08:34 am EDT
More quotes
Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Annual General Meeting
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.21% | 20.03M | |
| +7.91% | 72.81B | |
| +12.64% | 9.13B | |
| -10.56% | 5.13B | |
| +58.79% | 4.99B | |
| +4.07% | 3.9B | |
| -16.90% | 2.48B | |
| +20.84% | 2.42B | |
| -26.13% | 2.32B | |
| +19.31% | 2.17B |
- Stock Market
- Equities
- CLBIO Stock
